19-58294142-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_021089.3(ZNF8):c.334G>A(p.Gly112Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000409 in 1,611,990 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_021089.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF8 | NM_021089.3 | c.334G>A | p.Gly112Ser | missense_variant | 4/4 | ENST00000621650.2 | NP_066575.2 | |
ZNF8-ERVK3-1 | NR_144447.1 | n.1912G>A | non_coding_transcript_exon_variant | 4/7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF8 | ENST00000621650.2 | c.334G>A | p.Gly112Ser | missense_variant | 4/4 | 1 | NM_021089.3 | ENSP00000477716 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000210 AC: 32AN: 152128Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000557 AC: 14AN: 251236Hom.: 0 AF XY: 0.0000368 AC XY: 5AN XY: 135774
GnomAD4 exome AF: 0.0000233 AC: 34AN: 1459862Hom.: 0 Cov.: 31 AF XY: 0.0000193 AC XY: 14AN XY: 725762
GnomAD4 genome AF: 0.000210 AC: 32AN: 152128Hom.: 0 Cov.: 32 AF XY: 0.000215 AC XY: 16AN XY: 74300
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 02, 2022 | The c.334G>A (p.G112S) alteration is located in exon 4 (coding exon 4) of the ZNF8 gene. This alteration results from a G to A substitution at nucleotide position 334, causing the glycine (G) at amino acid position 112 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at